The site offers API process development and manufacturing from preclinical to commercial manufacturing. The site has 5 plants, including plants for HPAPI, enzyme fermentation and flow chemistry plants. The total reactor volume is nearly 400 m³.
It supports various API enabling technologies such as crystallization and particle engineering, biocatalysis, continuous manufacturing (flow chemistry), chemo-catalysis, and prep-HPLC & SFC & SMB.
Our Jinshan site has successfully passed numerous inspections by the US FDA, EMA, China NMPA, Japan PMDA, South Korea MFDS, and Brazil ANVISA.
